Rituximab for the Treatment of Early Rheumatoid Arthritis (RA)
Clinical trial NCT00396812 · TERMINATED
Trial details
- NCT number
- NCT00396812
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2009-07-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.